Point72 Asset Management L.P. bought a new stake in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 9,484 shares of the insurance provider's stock, valued at approximately $489,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Isthmus Partners LLC grew its stake in shares of AMERISAFE by 0.5% during the fourth quarter. Isthmus Partners LLC now owns 63,926 shares of the insurance provider's stock worth $3,295,000 after acquiring an additional 316 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of AMERISAFE by 3.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,842 shares of the insurance provider's stock worth $559,000 after acquiring an additional 357 shares during the last quarter. Values First Advisors Inc. grew its stake in shares of AMERISAFE by 8.2% during the fourth quarter. Values First Advisors Inc. now owns 5,350 shares of the insurance provider's stock worth $276,000 after acquiring an additional 404 shares during the last quarter. Bank of Montreal Can grew its stake in shares of AMERISAFE by 4.6% during the fourth quarter. Bank of Montreal Can now owns 9,375 shares of the insurance provider's stock worth $483,000 after acquiring an additional 410 shares during the last quarter. Finally, Illinois Municipal Retirement Fund grew its stake in shares of AMERISAFE by 4.1% during the fourth quarter. Illinois Municipal Retirement Fund now owns 10,904 shares of the insurance provider's stock worth $562,000 after acquiring an additional 428 shares during the last quarter. Hedge funds and other institutional investors own 97.41% of the company's stock.
AMERISAFE Stock Up 0.0%
Shares of AMERISAFE stock traded up $0.02 on Thursday, reaching $46.47. 13,359 shares of the stock were exchanged, compared to its average volume of 109,068. AMERISAFE, Inc. has a twelve month low of $41.97 and a twelve month high of $60.24. The firm has a market capitalization of $885.25 million, a price-to-earnings ratio of 14.52 and a beta of 0.41. The business has a 50 day moving average price of $48.80 and a two-hundred day moving average price of $51.25.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last released its earnings results on Tuesday, April 29th. The insurance provider reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.59 by $0.01. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. The firm had revenue of $83.78 million during the quarter, compared to the consensus estimate of $76.66 million. Research analysts forecast that AMERISAFE, Inc. will post 2.45 EPS for the current year.
AMERISAFE Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 13th will be issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 3.36%. The ex-dividend date of this dividend is Friday, June 13th. AMERISAFE's dividend payout ratio (DPR) is 62.90%.
Analysts Set New Price Targets
Separately, JMP Securities restated a "market outperform" rating and set a $65.00 price target on shares of AMERISAFE in a research note on Wednesday, April 30th.
View Our Latest Report on AMSF
AMERISAFE Company Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Read More

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.